并购战愈演愈烈:辉瑞诺、诺德百亿美元竞购“减肥药新贵”Metsera

华尔街见闻
Nov 06, 2025

周一美国市场一日内宣布四笔总额超800亿美元的大型交易,将今年的并购狂潮推向新高。在此背景下,制药巨头辉瑞与诺和诺德对“减肥药新贵”Metsera的竞购战也进入白热化阶段。 据英国《金融时报》援引两位知情人士消息,辉瑞已在周三的截止日期前提交了新报价,将方案提升至与诺和诺德持平的水平:每股86.20美元,总价最高100亿美元。 此举使辉瑞得以继续留在牌桌上。此前,Metsera董事会曾判定其丹麦...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10